Pregnant and lactating women are considered “therapeutic orphans” because they
generally have been excluded from clinical drug research and the drug development …

Women's health has been critically underserved by a failure to look beyond women's sexual
and reproductive systems to adequately consider their broader health needs. In almost …

Sex is a biological variable that contributes to individual variability in brain structure and
behavior. Neuroimaging studies of population‐based samples have identified normative …

Vaccinations during pregnancy can protect the mother from several infections, thus blocking
vertical transmission. Furthermore, through passive antibody transfer, the newborn can be …

As pregnant individuals have traditionally been excluded from clinical trials, there is a gap in
knowledge at the time of drug approval regarding safety, efficacy, and appropriate dosing for …

Pregnant women are still considered as drug orphans. Developing new medications for
pregnancy complications is an urgent need. Nanomedicines seem to be a promising …

Perinatal medicine and pharmacology focus on the wellbeing and health of women and
newborns throughout all stages of pregnancy, from conception to birth, and in the first year of …

Racial and ethnic marginalized populations have historically been poorly represented,
underrecruited, and underprioritized across clinical trials enrolling pregnant and lactating …

Background About 800 women die every day worldwide from pregnancy‐related
complications, including excessive blood loss, infections and high‐blood pressure (World …

There remains a paucity of literature on musculoskeletal dysfunction, biomechanics, and
pathologies of the lower extremity during pregnancy. There are a multitude of physiologic …